Report Detail
Global Cell Line Development Serum Market Insights, Forecast to 2025
- RnM2989596 |
- 20 February, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
The global Cell Line Development Serum market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cell Line Development Serum market based on company, product type, end user and key regions.
This report studies the global market size of Cell Line Development Serum in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cell Line Development Serum in these regions.
This research report categorizes the global Cell Line Development Serum market by top players/brands, region, type and end user. This report also studies the global Cell Line Development Serum market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
American Type Culture Collection (ATCC) (U.S.)
Lonza Group AG (Switzerland)
Thermo Fisher Scientific, Inc. (U.S.)
GE Healthcare (U.K.)
Sigma-Aldrich Corporation (U.S.)
Selexis SA (Switzerland)
European Collection of Cell Cultures (ECACC) (U.K.)
Corning, Inc. (U.S.)
WuXi AppTec, Inc. (China)
Sartorious AG (Germany)
Market size by Product
Fetal Bovine Serum
Adult Bovine Serum
Others
Market size by End User
Tissue Engineering & Regenerative Medicines
Toxicity Testing
Research
Drug Discovery
Bioproduction
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Cell Line Development Serum market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cell Line Development Serum market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cell Line Development Serum companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cell Line Development Serum submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Cell Line Development Serum are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cell Line Development Serum market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Cell Line Development Serum Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Cell Line Development Serum Market Size Growth Rate by Product
- 1.4.2 Fetal Bovine Serum
- 1.4.3 Adult Bovine Serum
- 1.4.4 Others
- 1.5 Market by End User
- 1.5.1 Global Cell Line Development Serum Market Size Growth Rate by End User
- 1.5.2 Tissue Engineering & Regenerative Medicines
- 1.5.3 Toxicity Testing
- 1.5.4 Research
- 1.5.5 Drug Discovery
- 1.5.6 Bioproduction
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Cell Line Development Serum Market Size
- 2.1.1 Global Cell Line Development Serum Revenue 2014-2025
- 2.1.2 Global Cell Line Development Serum Sales 2014-2025
- 2.2 Cell Line Development Serum Growth Rate by Regions
- 2.2.1 Global Cell Line Development Serum Sales by Regions
- 2.2.2 Global Cell Line Development Serum Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Cell Line Development Serum Sales by Manufacturers
- 3.1.1 Cell Line Development Serum Sales by Manufacturers
- 3.1.2 Cell Line Development Serum Sales Market Share by Manufacturers
- 3.1.3 Global Cell Line Development Serum Market Concentration Ratio (CR5 and HHI)
- 3.2 Cell Line Development Serum Revenue by Manufacturers
- 3.2.1 Cell Line Development Serum Revenue by Manufacturers (2014-2019)
- 3.2.2 Cell Line Development Serum Revenue Share by Manufacturers (2014-2019)
- 3.3 Cell Line Development Serum Price by Manufacturers
- 3.4 Cell Line Development Serum Manufacturing Base Distribution, Product Types
- 3.4.1 Cell Line Development Serum Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Cell Line Development Serum Product Type
- 3.4.3 Date of International Manufacturers Enter into Cell Line Development Serum Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Cell Line Development Serum Sales by Product
- 4.2 Global Cell Line Development Serum Revenue by Product
- 4.3 Cell Line Development Serum Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Cell Line Development Serum Breakdown Data by End User
6 North America
- 6.1 North America Cell Line Development Serum by Countries
- 6.1.1 North America Cell Line Development Serum Sales by Countries
- 6.1.2 North America Cell Line Development Serum Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Cell Line Development Serum by Product
- 6.3 North America Cell Line Development Serum by End User
7 Europe
- 7.1 Europe Cell Line Development Serum by Countries
- 7.1.1 Europe Cell Line Development Serum Sales by Countries
- 7.1.2 Europe Cell Line Development Serum Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Cell Line Development Serum by Product
- 7.3 Europe Cell Line Development Serum by End User
8 Asia Pacific
- 8.1 Asia Pacific Cell Line Development Serum by Countries
- 8.1.1 Asia Pacific Cell Line Development Serum Sales by Countries
- 8.1.2 Asia Pacific Cell Line Development Serum Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Cell Line Development Serum by Product
- 8.3 Asia Pacific Cell Line Development Serum by End User
9 Central & South America
- 9.1 Central & South America Cell Line Development Serum by Countries
- 9.1.1 Central & South America Cell Line Development Serum Sales by Countries
- 9.1.2 Central & South America Cell Line Development Serum Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Cell Line Development Serum by Product
- 9.3 Central & South America Cell Line Development Serum by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Cell Line Development Serum by Countries
- 10.1.1 Middle East and Africa Cell Line Development Serum Sales by Countries
- 10.1.2 Middle East and Africa Cell Line Development Serum Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Cell Line Development Serum by Product
- 10.3 Middle East and Africa Cell Line Development Serum by End User
11 Company Profiles
- 11.1 American Type Culture Collection (ATCC) (U.S.)
- 11.1.1 American Type Culture Collection (ATCC) (U.S.) Company Details
- 11.1.2 Company Business Overview
- 11.1.3 American Type Culture Collection (ATCC) (U.S.) Cell Line Development Serum Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 American Type Culture Collection (ATCC) (U.S.) Cell Line Development Serum Products Offered
- 11.1.5 American Type Culture Collection (ATCC) (U.S.) Recent Development
- 11.2 Lonza Group AG (Switzerland)
- 11.2.1 Lonza Group AG (Switzerland) Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Lonza Group AG (Switzerland) Cell Line Development Serum Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Lonza Group AG (Switzerland) Cell Line Development Serum Products Offered
- 11.2.5 Lonza Group AG (Switzerland) Recent Development
- 11.3 Thermo Fisher Scientific, Inc. (U.S.)
- 11.3.1 Thermo Fisher Scientific, Inc. (U.S.) Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Thermo Fisher Scientific, Inc. (U.S.) Cell Line Development Serum Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Thermo Fisher Scientific, Inc. (U.S.) Cell Line Development Serum Products Offered
- 11.3.5 Thermo Fisher Scientific, Inc. (U.S.) Recent Development
- 11.4 GE Healthcare (U.K.)
- 11.4.1 GE Healthcare (U.K.) Company Details
- 11.4.2 Company Business Overview
- 11.4.3 GE Healthcare (U.K.) Cell Line Development Serum Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 GE Healthcare (U.K.) Cell Line Development Serum Products Offered
- 11.4.5 GE Healthcare (U.K.) Recent Development
- 11.5 Sigma-Aldrich Corporation (U.S.)
- 11.5.1 Sigma-Aldrich Corporation (U.S.) Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Sigma-Aldrich Corporation (U.S.) Cell Line Development Serum Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Sigma-Aldrich Corporation (U.S.) Cell Line Development Serum Products Offered
- 11.5.5 Sigma-Aldrich Corporation (U.S.) Recent Development
- 11.6 Selexis SA (Switzerland)
- 11.6.1 Selexis SA (Switzerland) Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Selexis SA (Switzerland) Cell Line Development Serum Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Selexis SA (Switzerland) Cell Line Development Serum Products Offered
- 11.6.5 Selexis SA (Switzerland) Recent Development
- 11.7 European Collection of Cell Cultures (ECACC) (U.K.)
- 11.7.1 European Collection of Cell Cultures (ECACC) (U.K.) Company Details
- 11.7.2 Company Business Overview
- 11.7.3 European Collection of Cell Cultures (ECACC) (U.K.) Cell Line Development Serum Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 European Collection of Cell Cultures (ECACC) (U.K.) Cell Line Development Serum Products Offered
- 11.7.5 European Collection of Cell Cultures (ECACC) (U.K.) Recent Development
- 11.8 Corning, Inc. (U.S.)
- 11.8.1 Corning, Inc. (U.S.) Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Corning, Inc. (U.S.) Cell Line Development Serum Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Corning, Inc. (U.S.) Cell Line Development Serum Products Offered
- 11.8.5 Corning, Inc. (U.S.) Recent Development
- 11.9 WuXi AppTec, Inc. (China)
- 11.9.1 WuXi AppTec, Inc. (China) Company Details
- 11.9.2 Company Business Overview
- 11.9.3 WuXi AppTec, Inc. (China) Cell Line Development Serum Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 WuXi AppTec, Inc. (China) Cell Line Development Serum Products Offered
- 11.9.5 WuXi AppTec, Inc. (China) Recent Development
- 11.10 Sartorious AG (Germany)
- 11.10.1 Sartorious AG (Germany) Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Sartorious AG (Germany) Cell Line Development Serum Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Sartorious AG (Germany) Cell Line Development Serum Products Offered
- 11.10.5 Sartorious AG (Germany) Recent Development
12 Future Forecast
- 12.1 Cell Line Development Serum Market Forecast by Regions
- 12.1.1 Global Cell Line Development Serum Sales Forecast by Regions 2019-2025
- 12.1.2 Global Cell Line Development Serum Revenue Forecast by Regions 2019-2025
- 12.2 Cell Line Development Serum Market Forecast by Product
- 12.2.1 Global Cell Line Development Serum Sales Forecast by Product 2019-2025
- 12.2.2 Global Cell Line Development Serum Revenue Forecast by Product 2019-2025
- 12.3 Cell Line Development Serum Market Forecast by End User
- 12.4 North America Cell Line Development Serum Forecast
- 12.5 Europe Cell Line Development Serum Forecast
- 12.6 Asia Pacific Cell Line Development Serum Forecast
- 12.7 Central & South America Cell Line Development Serum Forecast
- 12.8 Middle East and Africa Cell Line Development Serum Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Cell Line Development Serum Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Cell Line Development Serum . Industry analysis & Market Report on Cell Line Development Serum is a syndicated market report, published as Global Cell Line Development Serum Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Cell Line Development Serum market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
